Insiders · EDSA

Patrick Marshall

Director at Edesa Biotech, Inc. (EDSA) since May 2023

Patrick Marshall has filed 6 insider reports with the SEC since May 2023, as director at Edesa Biotech, Inc. (EDSA). The latest filing, on May 29, 2026, reports grant or award at Edesa Biotech, Inc. (EDSA).

Filings
6
Companies
1
Bought on market
None
Sold on market
None

Companies where Patrick Marshall is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Edesa Biotech, Inc. logo
EDSA
Edesa Biotech, Inc.
Directorsince May 202371,666$1.96May 29, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Patrick Marshall with

Other insiders at the same companies

Questions about Patrick Marshall

What is Patrick Marshall's role at Edesa Biotech, Inc.?
Patrick Marshall reports to the SEC as director at Edesa Biotech, Inc. (EDSA), according to the latest filing on May 29, 2026.
How many shares does Patrick Marshall own?
After the latest filing that states it, Patrick Marshall directly owned 71,666 shares of Edesa Biotech, Inc. (EDSA). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Patrick Marshall bought or sold stock recently?
No open-market purchases or sales by Patrick Marshall are on file. The filings report grant or award.
How do I get alerts when Patrick Marshall files?
Follow Patrick Marshall on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Patrick Marshall (SEC CIK 0001978257). Totals count each trade once, skipping amendments whose original is on file, from May 24, 2023 on. View on SEC EDGAR